Neglected Tropical Diseases Diagnosis Market

Neglected Tropical Diseases Diagnosis Market by Diseases (Dengue, Chikungunya, Rabies, Leprosy, Buruli Ulcer, Yaws, and Others), Diagnostic Methods (Conventional and Molecular/Modern), Service Types (Centralized Service and POC Service), End-users (Clinical Labs, Hospitals/Clinics, and Home Healthcare), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021–2028

  • Report ID: HC-1228
  • Author: Growth Market Reports
  • Rating: 4.7
  • Total Reviews: 2
  • No. Of Pages: 150
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global neglected tropical diseases diagnosis market size is projected to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increase in prevalence of diseases such as dengue, chikungunya, and lymphatic filariasis.

Neglected Tropical Diseases Diagnosis Market Key Takeaways

In the recent years, neglected tropical diseases (NTDs) has been a low level of attention among medical and healthcare issues as compared to other diseases such as HIV and Malaria. However, they are now gaining high traction from healthcare organizations due to rapid funding for R&D of diagnostic methods and treatment options. The introduction of significant number of programs aiming to combat NTDs has contributed to the market growth. For instance, the Global Network for Neglected Tropical Diseases is aimed at raising awareness and funding regarding the diseases to eliminate and prevent from NTDs. Additionally, several companies are adopting various efforts for the development of less complicated and inexpensive diagnostic assays for tropical diseases.

Increasing demand for rapid diagnostic and highly sensitive test kits present key aspects for the market development. Diagnostics is necessary for the planning of the treatment, which is expected to lead to increasing demand for relevant diagnostic tests. Several business organizations are forming strategic alliances with several other laboratory-based clinical firms for the development and commercialization of novel detection assays, which in turn driving to propel the targeting NTDs products.

Market Drivers, Restraints, Trends, and Opportunities

  • Increasing demand for early detection of disease, rise in disease burden, and recent advancements in technology are projected to drive the market growth during the forecast period.
  • Growing awareness of people regarding the NTDs and its global impact on population due to several governments’ initiatives across the globe are anticipated to boost the demand for developing methods for early disease detection.
  • Introduction of NTDs in the goals of sustainable development and development of new programs to tackle NTDs are projected to spur the market growth during the forecast period.
  • Active participation of many international health organizations such as PATH has accelerated the development and implementation of various diagnostic methods for such diseases.
  • The outbreak of COVID-19 pandemic has adversely affected the disease diagnosis market. Shortage of workforce due to Sars-Cov-2 infection diagnosis and health safety challenges are projected to hamper the market growth.

Scope of the Report

The report on the neglected tropical diseases diagnosis market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Neglected Tropical Diseases Diagnosis Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Diseases (Dengue, Chikungunya, Rabies, Leprosy, Buruli Ulcer, Yaws, and Others), Diagnostic Methods (Conventional and Molecular/Modern), Service Types (Centralized Service and POC Service), and End-users (Clinical Labs, Hospitals/Clinics, and Home Healthcare)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

F. Hoffmann-La Roche Ltd., Abbott, Thermo Fisher Scientific, Inc., ZeptoMetrix, InBios International, Inc., Genome Diagnostics Pvt. Ltd, Omega Diagnostics Group PLC, Coris Bioconcept SPRL, DiaSys Diagnostic Systems GmbH, and Oscar Medicare Pvt Ltd.


Global Neglected Tropical Diseases Diagnosis Market Segment Insights

Dengue segment is projected to constitute a significant market share
On the basis of disease types, the neglected tropical diseases diagnosis market is divided into dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, and others. The dengue segment is projected to constitute a significant market share during the forecast period. The healthcare companies and institutes are undertaking continuous efforts for development and commercialization of less complicated diagnostic platforms for controlling and preventing dengue across the globe. For instance, in November 2014, companies such as Bio-Rad and Alere conducted a research study to evaluate the effectiveness of dengue NS1 antigen rapid tests and ELISA kits, for early diagnosis of the disease.

According to a report by World Health Organization (WHO), in April 2017, the incidence of dengue had been substantial increasing across the globe and stated that 50% of the world’s population is at a risk of contracting the disease.

Conventional segment to account for a considerable market share
Based on diagnostic methods, the market is bifurcated into conventional and molecular/modern. The conventional segment is anticipated to account for a considerable market share during the forecast period owing to wide adoption of the type of conventional diagnostic method. The conventional diagnostic method includes macroscopic and microscopic determination of pathogens through gram stain, pathogen culturing, biochemical methods, and serology tests. Moreover, these methods are widely available across a large number of labs and clinics than its modern counterparts. Additionally, rapidly growing advancements in the technology are impacting to increase more end-users towards modern methods. However, these tests have limitations regarding speed, timeline, and accuracy.

On the other hand, the molecular/modern segment is projected to expand at a high CAGR during the forecast period since the methods have a wide range of applications such as outpatient monitoring, large screening programs in developing regions, and point-of-care (POCT) testing.

Neglected Tropical Diseases Diagnosis Market By Diagnostic Methods

Centralized service segment is expected to represent a large market share
In terms of service types, the neglected tropical diseases diagnosis market is bifurcated into centralized services and POC services. The centralized service segment is expected to represent a large market share owing to the local presence of a wide range of facilities across the globe.

The POC segment, however, is projected to expand at a healthy CAGR during the forecast period. POC devices offers various advantages such as portability and easy usage, this is projected to boost the adoption of the POC devices. Additionally, these services provide immediate treatment, quick results, and better patient outcomes. For instance, the US Food and Drug Administration (FDA) granted the “Chagas Detect Plus Rapid Test Kit” a 510K clearance, a POCT for chagas disease by developed by InBios International.

Clinical labs segment is projected to represent a large market share
On the basis of end-uses, the market is divided into clinical labs, hospitals/clinics, and home healthcare. The clinical labs segment is projected to represent a large market share during the forecast period owing to the presence of a significant number of laboratories across the globe. Moreover, growing number of skilled personnel in laboratories is projected to boost the segment growth further. On the other hand, the home healthcare segment is anticipated to expand at a substantial CAGR during the forecast period owing to the increasing adoption of POCT devices. Furthermore, this segment offers improved access to healthcare in remote and rural areas.

Neglected Tropical Diseases Diagnosis Market By End Users

Latin America region is projected to account for a considerable market share
In terms of regions, the neglected tropical diseases diagnosis market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Latin America is projected to account for a considerable market share during the forecast period owing to growing awareness of people regarding ways of tackling NTDs in the region. Meanwhile, the market in Asia Pacific is expected to expand at a substantial CAGR during the forecast period. The rapid growth in the healthcare infrastructure of major economies in Asia such as India and China is driving the regional market growth. The presence of a large population, continuous growth in GDP, and high prevalence of NTDs in this region is driving the market growth in Asia Pacific.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neglected Tropical Diseases Diagnosis Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Neglected Tropical Diseases Diagnosis Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Neglected Tropical Diseases Diagnosis Market - Supply Chain
  4.5. Global Neglected Tropical Diseases Diagnosis Market Forecast
     4.5.1. Neglected Tropical Diseases Diagnosis Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Neglected Tropical Diseases Diagnosis Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Neglected Tropical Diseases Diagnosis Market Absolute $ Opportunity
5. Global Neglected Tropical Diseases Diagnosis Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by End Users
     5.3.1. Clinical Labs Hospitals/Clinics Home Healthcare
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Neglected Tropical Diseases Diagnosis Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Neglected Tropical Diseases Diagnosis Demand Share Forecast, 2019-2026
7. North America Neglected Tropical Diseases Diagnosis Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by End Users
     7.4.1. Clinical Labs Hospitals/Clinics Home Healthcare
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Neglected Tropical Diseases Diagnosis Demand Share Forecast, 2019-2026
8. Latin America Neglected Tropical Diseases Diagnosis Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by End Users
     8.4.1. Clinical Labs Hospitals/Clinics Home Healthcare
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Neglected Tropical Diseases Diagnosis Demand Share Forecast, 2019-2026
9. Europe Neglected Tropical Diseases Diagnosis Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by End Users
     9.4.1. Clinical Labs Hospitals/Clinics Home Healthcare
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Neglected Tropical Diseases Diagnosis Demand Share Forecast, 2019-2026
10. Asia Pacific Neglected Tropical Diseases Diagnosis Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by End Users
     10.4.1. Clinical Labs Hospitals/Clinics Home Healthcare
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Neglected Tropical Diseases Diagnosis Demand Share Forecast, 2019-2026
11. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Neglected Tropical Diseases Diagnosis Market Size and Volume Forecast by End Users
     11.4.1. Clinical Labs Hospitals/Clinics Home Healthcare
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Neglected Tropical Diseases Diagnosis Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Neglected Tropical Diseases Diagnosis Market: Market Share Analysis
  12.2. Neglected Tropical Diseases Diagnosis Distributors and Customers
  12.3. Neglected Tropical Diseases Diagnosis Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. F. Hoffmann-La Roche Ltd. Abbott Thermo Fisher Scientific, Inc. ZeptoMetrix InBios International, Inc. Genome Diagnostics Pvt. Ltd Omega Diagnostics Group PLC Coris Bioconcept SPRL
Segments Covered in the Report
The global neglected tropical disease diagnostic market has been segmented on the basis of

Diseases
  • Dengue
  • Chikungunya
  • Rabies
  • Leprosy
  • Buruli Ulcer
  • Yaws
  • Others
Diagnostic Methods
  • Conventional
  • Molecular/Modern
Service Types
  • Centralized Service
  • POC Service
End-users
  • Clinical Labs
  • Hospitals/Clinics
  • Home Healthcare
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • F. Hoffmann-La Roche Ltd.
  • Abbott
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix
  • InBios International, Inc.
  • Genome Diagnostics Pvt. Ltd
  • Omega Diagnostics Group PLC
  • Coris Bioconcept SPRL
  • DiaSys Diagnostic Systems GmbH
  • Oscar Medicare Pvt Ltd.

Some of the prominent players competing in global neglected tropical diseases diagnosis market are F. Hoffmann-La Roche Ltd., Abbott, Thermo Fisher Scientific, Inc., ZeptoMetrix, InBios International, Inc., Genome Diagnostics Pvt. Ltd, Omega Diagnostics Group PLC, Coris Bioconcept SPRL, DiaSys Diagnostic Systems GmbH, and Oscar Medicare Pvt Ltd. Key players are constantly focusing on strategic initiatives such as new product development, collaborations, and partnerships to increase their market position and existing share control in the market.

Neglected Tropical Diseases Diagnosis Market By Key Players

Buy Report